CRISPR Market: By Product Type, By Application, By Distribution Channel, and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

CRISPR Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Vector-based Cas, DNA-free Cas), By Application (Functional Genomics, Knockdown/activation, Genome Engineering, Disease models, Other Applications), By Distribution Channel (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others), and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

CRISPR Market size was valued at US$ 2,987.2 million in 2023 and is expected to reach US$ 5,068.9 million by 2030, at a CAGR of 24.6% from 2024-2030. CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeat. CRISPR is also called as CRISPR/Cas9. The scientific world is attracted by this revolutionary technology. CRISPR technology is a simple yet powerful tool that is used for editing genomes. This technology is used to alter the DNA sequence and modify gene function. Its major application includes correcting genetic defects, treating, and preventing the spread of diseases and is also used improving crops.

The technological advancements are the key factors attributed for the growth of the market. Increase in the prevalence of genetic and growing drug discovery activities are expected to boost the market revenue growth. The growing demand for synthetic genes and increase in the R&D expenditure on biotechnology and raising government expenditure on genetic research is enriching the growth of the market. However, complications such as gene editing of germ line cells are hindering the growth of the market. Since the changes made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is illegal in most of the countries such as the UK. Limited awareness is another factor hindering the growth of the market.

summary download arrow Download Free Sample

Crispr Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

24.6%

Largest Market

North-America

Fastest Growing Market

Asia Pacific

CRISPR Market Dynamics

During the projected period, technological developments in CRISPR and the launch of anti-CRISPR proteins are expected to drive the market. The market is predicted to develop due to the growing acceptance of CRISPR technology in pharmaceuticals, epigenetics, plant genome editing, human germline editing, and other disciplines of biotechnology. CRISPR-Cas systems also have uses in culture immunisation, self-targeted cell death, bacterial strain typing, and altering metabolic pathways to increase biochemical synthesis, all of which contribute to the global market's expansion.

Crispr Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 2,987.2 million

Market Size in 2030

US$ 5,068.9 million

Market CAGR

24.6%

By Product Type

  • Vector-based Cas
  • DNA-free Cas

By Application

  • Functional Genomics
  • Knockdown/activation
  • Genome Engineering
  • Disease models
  • Other Applications

By Distribution Channel

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The crispr market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global crispr market size was valued at US$ 2,987.2 million in 2023 and is projected to grow at a CAGR of 24.6% from 2024 to 2030

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA

The key players of the market are Transposagen Biopharmaceuticals (U.S) Agilent Technologies, Inc. (U.S) Merck KGaA (Germany) Rockland Immunochemicals, Inc. (U.S) Applied StemCell, Inc. (U.S) Cellecta, Inc. (U.S) GeneCopoeia, Inc. (U.S) Horizon Discovery plc (UK) Mirus Bio LLC (U.S) New England Biolabs (U.S)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Crispr Market Introduction 
2.1.Global Crispr Market  - Taxonomy
2.2.Global Crispr Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.Distribution Channel
2.2.4.Region
3.Global Crispr Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Crispr Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Crispr Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Vector-based Cas
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. DNA-free Cas
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Crispr Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Functional Genomics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Knockdown/activation
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Genome Engineering
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Disease models
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Other Applications
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Crispr Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Biotechnology & Pharmaceutical Companies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Academic & Government Research Institutes
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Crispr Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Crispr Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Vector-based Cas
9.1.2.DNA-free Cas
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Functional Genomics
9.2.2.Knockdown/activation
9.2.3.Genome Engineering
9.2.4.Disease models
9.2.5.Other Applications
9.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Biotechnology & Pharmaceutical Companies
9.3.2.Academic & Government Research Institutes
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Crispr Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Vector-based Cas
10.1.2.DNA-free Cas
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Functional Genomics
10.2.2.Knockdown/activation
10.2.3.Genome Engineering
10.2.4.Disease models
10.2.5.Other Applications
10.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Biotechnology & Pharmaceutical Companies
10.3.2.Academic & Government Research Institutes
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Crispr Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Vector-based Cas
11.1.2.DNA-free Cas
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Functional Genomics
11.2.2.Knockdown/activation
11.2.3.Genome Engineering
11.2.4.Disease models
11.2.5.Other Applications
11.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Biotechnology & Pharmaceutical Companies
11.3.2.Academic & Government Research Institutes
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Crispr Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Vector-based Cas
12.1.2.DNA-free Cas
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Functional Genomics
12.2.2.Knockdown/activation
12.2.3.Genome Engineering
12.2.4.Disease models
12.2.5.Other Applications
12.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Biotechnology & Pharmaceutical Companies
12.3.2.Academic & Government Research Institutes
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Crispr Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Vector-based Cas
13.1.2.DNA-free Cas
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Functional Genomics
13.2.2.Knockdown/activation
13.2.3.Genome Engineering
13.2.4.Disease models
13.2.5.Other Applications
13.3.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Biotechnology & Pharmaceutical Companies
13.3.2.Academic & Government Research Institutes
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Transposagen Biopharmaceuticals (U.S)
14.2.2.Agilent Technologies, Inc. (U.S)
14.2.3.Merck KGaA (Germany)
14.2.4.Rockland Immunochemicals, Inc. (U.S)
14.2.5.Applied StemCell, Inc. (U.S)
14.2.6.Cellecta, Inc. (U.S)
14.2.7.GeneCopoeia, Inc. (U.S)
14.2.8.Horizon Discovery plc (UK)
14.2.9.Mirus Bio LLC (U.S)
14.2.10.New England Biolabs (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Transposagen Biopharmaceuticals (U.S)
  • Agilent Technologies, Inc. (U.S)
  • Merck KGaA (Germany)
  • Rockland Immunochemicals, Inc. (U.S)
  • Applied StemCell, Inc. (U.S)
  • Cellecta, Inc. (U.S)
  • GeneCopoeia, Inc. (U.S)
  • Horizon Discovery plc (UK)
  • Mirus Bio LLC (U.S)
  • New England Biolabs (U.S)

Related Industry Reports

DNA Diagnostics Market

Media Sera and Reagents Market in Biotechnology

Dna Vaccines Market

Global Infectious Disease Therapeutics Market